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Peroral endoscopic myotomy (POEM) is the application of esophageal myotomy to the concept of natural orifice transluminal surgery 
(NOTES) by utilizing a submucosal tunneling method. Since the first case of POEM was performed for treating achalasia in Japan 
in 2008, this procedure is being more widely used by many skillful endosopists all over the world. Currently, POEM is a spotlighted, 
emerging treatment option for achalasia, and the indications for POEM are expanding to include long-standing, sigmoid shaped 
esophagus in achalasia, even previously failed endoscopic treatment or surgical myotomy, and other spastic esophageal motility 
disorders. Accumulating data about POEM demonstrate excellent short-term outcomes with minimal risk of major adverse events, and 
some existing long-term data show the efficacy of POEM to be long lasting. In this review article, we review the technical details and 
clinical outcomes of POEM, and discuss some considerations of POEM in special situations.
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Backgrounds  
Achalasia and the History of Peroral Endoscopic 
Myotomy
Surgical myotomy has been the most reliable treatment of 
choice for treating esophageal achalasia since the first report by 
Heller in 1913.1 Other management methods include medication, 
balloon dilatation,2,3 and botulinum toxin injection,4,5 which are still 
inconclusive because of the relatively low efficacy and also relatively 
high complication rates. 
The concept of natural orifice transluminal endoscopic surgery 
(NOTES) was introduced by Kalloo and his colleagues.6,7 Under 
the influence of the rapidly increasing demands for less-invasive 
treatment, Inoue et al8 introduced peroral endoscopic myotomy 
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(POEM) in humans as a non-surgical treatment method for 
esophageal achalasia in 2010. Since then, POEM has been one of 
the standard treatments for treating esophageal achalasia and related 
esophageal motility diseases, such as diffuse esophageal spasm and 
jackhammer esophagus.8-10 
Table 1 summarizes the general characteristics of POEM com-
pared with laparoscopic Heller myotomy and pneumatic dilation.
Procedure of Peroral Endoscopic Myotomy  
Indications
The indications for POEM encompass the conditions that are 
responsible for the excessive behavior of the inner circular muscle 
layer. Unlike other options, POEM theoretically allows myotomy 
to be performed for muscles of any length, position, and direction 
because of its intraluminal route of approach. Therefore, esopha-
geal achalasia is the most cardinal indication. Furthermore, diffuse 
esophageal spasm (distal esophageal spasm, DES), jackhammer 
esophagus, and surgically failed cases, all of which require flex-
ible myotomy depending on the condition in each case, can also be 
recommended indications.11 Moreover, POEM may be the only 
option for surgically failed cases because surgical re-do myotomy 
is extremely difficult due to the fibrosis and scarring as a result of 
previous surgery.
Pre-operative Evaluation
Esophagogastroduodenoscopy (EGD), barium swallow, and 
manometry should be performed preoperatively in order to confirm 
the diagnosis and the treatment strategy. Evaluation of the shape of 
the esophagus, disease progression grade, and dynamic observation 
of the esophagus is mandatory to comprehend the pathology of the 
disease. 
EGD enables us to assess the width of the esophagus, the 
amount of the esophageal contents, and abnormal movement of 
the esophageal body. EGD is also requisite to rule out pseudo-
achalasia; computed tomography or endoscopic ultrasound is also 
required to rule out submucosal cancer in the esophagus/gastric car-
dia, or extrinsic compression due to lymph node swelling or tumors 
of the adjacent structures.12 Because achalasia is a high-risk factor of 
esophageal cancer, direct visualization of the mucosal surface is quite 
important in order to detect the early signs of esophageal cancer. 
According to the shape of the esophagus, achalasia patients 
are classified as having the straight or sigmoid type with severe 
tortuosity. The maximum diameter of the thoracic esophagus is also 
measured. Barium esophagogram allows us to visualize important 
information about the dynamics of the esophagus, such as the site 
of abnormal contraction, simultaneous contraction, and barium 
accumulation. Timed barium esophagogram (TBE) measures the 
distance from the distal esophagus to the top of a distinct retained 
barium column (barium height) and the maximal esophageal width 
(barium width) at 1, 2, and 5 minutes after barium ingestion. TBE 
is a noninvasive and effective method in both the diagnosis and 
evaluation of response to treatment of achalasia.
Esophageal manometry is another essential examination suit-
able for the evaluation of detailed esophageal function. The Chicago 
classification of esophageal motility was developed by Bredenoord 
et al13 who interpreted the results of clinical high-resolution ma-
Table 1. Characteristics of Peroral Endoscopic Myotomy Compared with Laparoscopic Heller Myotomy and Pneumatic Dilation
POEM LHM PD
Scarring No Yes No
Selective circular myotomy Possible No No
Concurrent anti-reflux procedure No Fundoplication No
Dissection and disruption of the diaphragmatic hiatus No Yes No
Postoperative incidence of GERD (+++) 
Symptomatic GERD 
  approximately 20-30%
(++)
Symptomatic GERD 
  approximately 15%
(+/–)
Myotomy extension to the proximal esophageal body Possible Difficult Impossible
Hospital stay Intermediate Relatively long Very short
Cost Intermediate (variable 
  according to region)
High Low
Clinical response for achalasia Good (excellent) Good Fair 
Clinical response for spastic esophageal disorders Good Fair Poor 
POEM, peroral endoscopic myotomy; LHM, laparoscopic Heller myotomy; PD, pneumatic dilation; GERD, gastroesophageal reflux disease.
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nometry (HRM) studies. The latest version of the classification was 
released in 2015, considering the updating technology and clinical 
practice.14 
Prerequisites 
Patients are admitted on the day before POEM and were 
asked to fast (no solid food) for 24 hours before the procedure. 
EGD is performed before the administration of general anesthesia 
in order to remove the food remnants from the esophagus prior to 
intubation. Patients are asked to lie in the supine position. Admin-
istration of broad-spectrum intravenous antibiotics is started before 
POEM for prevention of infection.
A forward-viewing endoscope is used with a transparent distal 
cap attachment (DH-28GR, FTS). A triangle tip knife (KD- 
640L; Olympus) or possibly other endoscopic knives can be used to 
dissect the submucosal layer and to divide circular muscle bundles. 
A coagulating forceps (Coagrasper, FD-411QR; Olympus) is used 
for vessel coagulation of larger vessels prior to dissection and for he-
mostasis. An electrogenerator, VIO 300D (ERBE, Tubingen, Ger-
many) is utilized. In addition, hemostatic clips (EZ-CLIP, HX- 
110QR; Olympus) are applied for the final closure of the mucosal 
entry site. The procedures are performed with the patient under 
general anesthesia with positive pressure ventilation. The UCR 
CO2 insufflator (Olympus) is used with a regular insufflating tube 
(MAJ-1742; Olympus), which maintains continuous CO2 insuffla-
tion at a constant rate of 1.2 liter/minute. 
Precise Operative Steps
The POEM procedure is performed as follows: 
1.  Approximately 10 mL saline supplemented with 0.3 % 
indigo carmine is injected into the submucosal space on the 
anterior (11-2 o’clock) or posterior (5 o’clock) wall of the 
mid-esophagus. Subsequently, a 2-cm longitudinal mucosal 
incision is made as a mucosal entry into the submucosal 
space (the dry cut mode [50 W, effect 3], or the Endocut 
I mode) (Fig. 1). Then, a technique similar to endoscopic 
submucosal dissection is used to create a submucosal tunnel 
approximately 2 or 3 cm into the proximal stomach (Fig. 2). 
The spray coagulation mode (40-60 W, effect 1-2) is used to 
dissect the submucosal layer. Larger vessels in the submu-
Figure 1. Entry to the submucosal space. 
After submucosal injection of saline and 
0.3% indigo carmine mixture, a 2-cm 
longitudinal mucosal incision is made at 
the mid esophagus.
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cosa are coagulated using the forceps in the soft coagulation 
mode (80 W, effect 5). The determination of anterior (11-2 
o’clock) or posterior (5 o’clock) position of submucosal tun-
neling and myotomy is up to the preference of the operator. 
Although there is few evidence, many experts suggest that 
posterior myotomy may have an advantage for relief of dys-
phagia, and anterior myotomy may be better in the preven-
tion of gastroesophageal reflux disease.
2.  Dissection of the circular muscle bundle is started at 2-3 cm 
distal from the mucosal entry by using a triangle tip knife 
(Fig. 3). The captured circular muscle is cut by using a 
spray coagulation current (40-60 W, effect 1-2), avoiding 
massive bleeding from the intra-muscular vessels. Division 
of the sphincter muscle is continued from the proximal side 
towards the stomach and 2 or 3 cm into the cardia (Fig. 3), 
according to the surgical standards of Heller myotomy. The 
esophagogastric junction (EGJ) is identified by recognizing 
one or more of the following: (1) the narrow segment of the 
esophageal lumen at the lower esophageal sphincter (LES) 
and opening in the stomach, (2) change of the vascular pat-
tern and palisade vessels that were identified when dissect-
ing the tunnel, as well as irregularly arranged vessels in the 
gastric cardia, (3) tattooing with indocyanine green by rec-
ognizing the color of indocyanine green injected prior to my-
otomy,15 and (4) double scope technique in which a second 
endoscope is used to obtain a retroflexed view of the gastric 
cardia, while the dissecting scope transilluminate from the 
end of the submucosal tunnel.16
3.  After completion of the myotomy, improvement of the en-
doscope passage at the EGJ is confirmed from inside the 
tunnel and the true esophageal lumen. The incised mucosal 
entry is closed with hemostatic clips after prophylactic antibi-
otic solution spraying inside the tunnel. Complete closure of 
the mucosal entry is confirmed endoscopically (Fig. 4). 
Postoperative Care
Oral intake of clear water is started after the esophagogram 
or EGD confirms the smooth passage of a contrast agent without 
leakage and absence of ischemic/hemorrhagic color change of the 
mucosa. On post-operative day 2, a soft diet is started. The use of 
intravenous antibiotics is discontinued 3 days after the procedure; 
antibiotics were switched to oral intake for another 7 days. 
Figure 2. Submucosal tunneling. A long 
submucosal tunnel is created 2-3 cm dis-
tal to the esophagogastric junction. The 
circular muscle fibers are perpendicular 
to the longitudinal direction of the tunnel.
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The functional evaluations including TBE, manometry and 
pH-metry as well as endoscopy are repeated 3-6 months after 
POEM in order to elucidate the effect of the procedure, complica-
tions, and changes to esophageal motility.17 
Outcomes of Peroral Endoscopic Myotomy  
Short-term Outcomes
Because POEM is a treatment option for symptomatic acha-
lasia or esophageal motility disorders, the most important measure 
in evaluating the clinical efficacy of POEM should be subjective 
symptoms. Most clinical series of POEM report pre- and post-
POEM Eckhart’s score as a subjective measure of treatment effi-
cacy, and mostly define clinical success as a post-POEM Eckhart’s 
score of < 3. The short-term clinical success of POEM was re-
ported to be 82% to 100% until 12 months, mostly > 90%, which 
is highly effective. Some studies also investigated the quality of life 
before and after POEM by using a standardized questionnaire, 
and showed that POEM provided significant improvement in the 
quality of life.24-27
For objective measurements of efficacy, various parameters can 
be compared before and after the treatment of achalasia. The objec-
tive parameters include barium column height in timed barium 
esophagograms (TBE),28,29 LES pressure, integrated relaxation 
pressure,30 and GE junction distensibility as measured by End-
oFLIP (Endolumenal Functional Lumen Imaging Probe; Cro-
spon, Galway, Ireland).31 Many studies regarding POEM reported 
not only subjective clinical symptomatic success, but also objective 
assessment. POEM has also demonstrated a significant reduction 
of TBE column height, LES pressure, and integrated relaxation 
pressure in most cases.19,26,32 EndoFLIP provides a quantitative as-
sessment of luminal patency and sphincter distension, and recently 
has been increasingly reported as a method of assessing the adequa-
cy of myotomy. EGJ distensibility measurements on EndoFLIP 
have been shown to correlate better with postoperative symptoms 
compared to manometric pressure measurements.33 Intraprocedural 
application of EndoFLIP to POEM was highly predictive of post-
operative symptomatic outcomes.34,35 
Along with the improvement of manometric profiles of EGJ, 
Figure 3. Endoscopic myotomy of cir-
cular muscle bundle begins from 2-3 cm 
distal to the mucosal entry and extends 
to 2-3 cm distal to the esophagogastric 
junction. By using a triangle tip knife, 
endoscopic myotomy of inner circular 
muscle bundles is done, leaving the 
outer longitudinal muscle layer intact.
19
Peroral Endoscopic Myotomy for Treating Achalasia and Esophageal Motility Disorders
Vol. 22, No. 1   January, 2016 (14-24)
some patients also experienced recovery of esophageal body peri-
stalsis after treatment of achalasia. There have been a few reports of 
recovery of esophageal body peristalsis after POEM for achalasia. 
Forty-seven percent of patients had partial recovery of peristalsis 
in an early European multicenter series of POEM,19 and 36% of 
achalasia patients in another single-center study showed some return 
of normal peristalsis (≥ 70% peristalsis) on post-operative HRM.36 
However, esophageal body peristalsis does not seem to be consis-
tently affected. Another recently published study demonstrated that 
only 2 of 66 patients had some degree of antegrade peristalsis after 
POEM.37 Further study is needed to clarify the recovery of esopha-
geal body peristalsis after POEM.
Long-term Outcomes
Long-term follow-up data after POEM are accumulating 
over time. A representative long-term follow-up study is the one 
performed by Inoue et al,38 who reported the outcomes of 500 con-
secutive patients treated with POEM with a follow-up of more than 
3 years. They showed that 2-month, 1- to 2-year, and 3-year overall 
success rates were 91.3%, 91.0%, and 88.5%, respectively.38 Table 2 
summarizes the findings of seven recently published studies that 
report the long-term outcomes of POEM after a follow-up of more 
than 1 year.19,36,38-42 Most of these series demonstrated a sustained 
clinical success of POEM in > 90% of patients, with the follow-up 
duration ranging from 12 months to > 36 months.19,36,38-42 How-
ever, one international prospective multicenter study showed some 
decline in clinical success over time.39 Von Renteln et al39 demon-
strated a 97% treatment success at 3 months, 88.5% at 6 months, 
and 82.4% at 12 months, which significantly declined from the 
initial treatment success. Although we cannot determine the exact 
reason of such a decline in the efficacy in this trial, one can suppose 
that it is probably due to the multicenter nature of this trial con-
ducted in the relatively early stage of the POEM era, because of the 
variability in experience and performance of the operators. 
To summarize, the literature to date supports the notion that 
the high efficacy of POEM generally seems to be durable and long 
lasting.
Complications of Peroral Endoscopic  
Myotomy  
As reported, the POEM procedure can be described as a sur-
Figure 4. Closure of the mucosal entry. 
The mucosal incision of entry point is 
completely closed with hemostatic clips.
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gical myotomy that is done in an endoscopic manner. Therefore, 
minor pneumomediastinum or pneumoperitoneum with minimum 
effects on perioperative course are not considered complications. 
So far, there have been considerably many studies regarding 
POEM against esophageal achalasia, with more than 1000 cases 
after introduction of the technique. Zhong and his colleagues col-
lected data about complications from their 119 cases in 2012.43 
Complications related to gas insufflation such as cutaneous emphy-
sema, pneumothorax, and pneumoperitoneum occurred in more 
than half of all the patients (subcutaneous emphysema [55.5%, 
66/119], pneumothorax [2.5%, 3/119], and pneumoperitoneum 
[39.5%, 47/119]). The use of CO2 as an insufflating gas and gen-
eral anesthesia with positive ventilation is necessary to avoid these 
complications. They mentioned that the incidence of these com-
plications significantly reduced after they started to use CO2 as an 
insufflating gas. 
They also reported that delayed hemorrhage occurred in 1 
patient. The patient recovered after conservative management after 
the blood clot was removed from the submucosal tunnel lumen by 
gastroscopy. Severe mediastinitis is another important post-operative 
complication. There have been also some reports of mediastinal 
leakage due to esophageal perforation, which needed thoracoscopic 
or laparoscopic drainage and extended hospital stay.20,27,44 Complete 
and precise closure of the entry site and careful observation after 
starting solid foods are important to avoid this unfavorable compli-
cation. 
In a recent literature published by Inoue and his colleagues, the 
incidence of adverse events related to the POEM procedure was < 
3.2%, including 1 case of pneumothorax, 1 case of severe bleeding, 
3 cases of post-operative hematomas, and 1 case of local peritonitis. 
All patients with these complications recovered with conservative 
treatment, and no procedure-related deaths were reported.38
Peroral Endoscopic Myotomy in Special  
Situations  
Pediatric Patients
One of the concerns regarding POEM would be the feasibil-
ity of this procedure in extremely young patients. However, there 
have been several case reports of successful POEM even in infants, 
resulting in a good clinical response without specific complica-
tions.45,46 In a recent relatively large series of POEM in 27 children 
with achalasia, the authors reported that a total of 26 patients (96.3%) 
underwent successful POEM. Submucosal tunneling failed in 1 
patient because of serious inflammation and adhesion. Among the 
26 children who received successful POEM, the clinical treatment 
success was maintained in all during a mean follow-up period of 
24.6 months (range 15-38 months), and no serious adverse events 
related to POEM were encountered.41 These data suggest that the 
efficacy and safety of POEM in pediatric achalasia patients are also 
promising, similar to those in adult patients. 
Previous Endoscopic and Surgical Treatment
There can be some concerns about the feasibility, safety, and 
efficacy of POEM in patients who have undergone previous endo-
scopic (botulinum toxin injections or pneumatic balloon dilation) 
or surgical treatment. Previous intervention at the EGJ may result 
in some degree of submucosal fibrosis that hinders safe submucosal 
tunneling through the EGJ. Previous interventions may possibly 
make the POEM procedure more difficult compared to that in 
treatment naïve patients. 
Table 2. Long-term Efficacy of Peroral Endoscopic Myotomy (Data from Published Studies in the Order of a Long Follow-up Duration)
Total subject  
number
Follow-up  
(months)
Clinical  
success
Eckardt score 
(before/after)
LES pressure 
(mmHg)
(before/after) 
Clinical GERD
(symptomatic 
or PPI use)
Inoue et al38 500 Over 36 88.5% 
(54/61)
6.0/1.7 28.7/14.0 21.3%
Hu et al40 32 (Sigmoid type) 30 (median) 96.8% 7.8/1.4 37.9/12.9 25.8%
Chen et al41 26 (pediatric patients) 24.6 (mean) 100% 8.3/0.7 31.6/12.9 19.2%
Sharata et al36 75 20.1 (mean) 97% 6/1 22.2/11.7 19.1%
Minami et al42 28 16 (median) 100% 6.7/0.7 71.2/21 21.4%
Teitelbaum et al19 41 15 months (median) 92% 7/1 28/11 15%
Von Renteln et al39 70 12 (median) 82.4% 6.9/1 27.6/8.9 29%
LES, lower esophageal sphincter; GERD, gastroesophageal reflux disease; PPI, proton pump inhibitor.
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Regarding previous endoscopic treatment, a study prospectively 
compared the POEM procedure in 30 naïve patients, with 21 pa-
tients who had undergone previous pneumatic dilation.47 This study 
showed a significantly longer operation time in the patients with 
previous pneumatic dilations; however, the outcomes in terms of 
the efficacy and safety were similar in both groups.47 Another study 
about the learning curve of POEM also showed that previous 
endoscopic treatment was one of the independent predictive factors 
of a longer procedure time.48 However, there were also several con-
trary results that showed no significant difference even in operation 
time, efficacy, and safety.49-51 
POEM could also be used in the setting of recurrence or fail-
ure after previous surgical myotomy. The results of three studies 
examining the utility of POEM in patients who have undergone 
a previous surgical myotomy have been published. Zhou et al52 
reported 12 patients, Onimaru et al11 reported 10 patients, and Vi-
gneswaran et al53 reported 5 patients, whose symptoms recurred af-
ter Heller myotomy; these patients subsequently underwent salvage 
POEM. All these series showed acceptable feasibility, safety, and 
relatively high clinical efficacy in the range of 91.7% to 100%.11,52,53
In conclusion, POEM in the setting of previous interventions 
seems to be equally safe and efficacious when performed by experts; 
however, it may be more technically challenging. Therefore, inex-
perienced POEM operators must be cautious while treating such 
cases.
Sigmoid-shaped Esophagus in Achalasia
Some advanced achalasia patients show progression to a sig-
moid esophagus due to severe dilatation and subsequent tortuous 
angulation of their esophageal lumen. Severe sigmoid esophagus 
can markedly increase the procedural difficulty of POEM. Pa-
tients with severe esophageal stasis could show inflammation and 
fibrosis of the submucosa, hindering submucosal tunneling; severe 
angulations also make the direction of submucosal tunneling very 
puzzling.17 In our experience, the deepest possible submucosal tun-
neling could help maintain the correct aboral direction of the sub-
mucosal tunnel by ensuring the direction to be perpendicular to the 
circular muscle fibers. Although some experts reported good fea-
sibility and efficacy of POEM even in these advanced patients,8,40 
these cases seem to be particularly challenging and should be per-
formed only by highly experienced operators.
Spastic Esophageal Disorders
Spastic esophageal disorders (SEDs) may include spastic acha-
lasia (type III achalasia), distal esophageal spasm (diffuse esopha-
geal spasm [DES]), and jackhammer esophagus.14 Although each 
of these disorders has a different pathophysiology, they share many 
similar clinical symptoms such as chest pain, regurgitation, and 
dysphagia. In terms of the coexistence of dysphagia and esophageal 
spasm, surgical myotomy is one of the best treatment options for 
SEDs.54 Similarly, POEM could also be applied for the treat-
ment of these SEDs, and there have been multiple case reports 
that showed that POEM had excellent clinical efficacy for various 
SEDs, including jackhammer esophagus, DES, or Nutcracker 
esophagus.9,10,55-59 The results of an international multicenter study 
of POEM for SEDs were recently published.60 This study col-
lected retrospective data of 9 patients with DES, 10 patients with 
jackhammer esophagus, and 54 patients with spastic achalasia from 
11 centers. Overall, a clinical response was observed in 93%, and 
the clinical response in each disease category was 100% in DES, 
96.3% in spastic achalasia and 70% in jackhammer esophagus, 
which was significantly lower than that of other diseases. The jack-
hammer esophagus possibly may be a more difficult entity to treat 
with POEM when compared to both spastic achalasia and DES. 
The authors suggested the reason for the diminished response of 
POEM in jackhammer esophagus seems to be related to the ex-
tremely high contractility of the esophageal body; they suggested 
the value of concomitant bilateral (anterior and posterior) myotomy 
as a possible alternative for such patients. However, we think that 
the length of myotomy is still the most important factor for clinical 
success in jackhammer esophagus. POEM for SEDs generally in-
volved long myotomy (mean length = 16 cm),60 which was almost 
double of that used in conventional POEM, because patients with 
these SEDs frequently have chest pain often associated with spastic 
contraction of the esophageal body.61 When the patient has chest 
pain (common in DES, jackhammer esophagus, and nutcracker 
esophagus), which may be related to abnormal spastic contractions, 
the POEM operator should take care to ensure the length of the 
myotomy extends to the area of the most proximal spastic contrac-
tion. However, in some cases with long spastic contraction of the 
esophageal body, such a long myotomy length might still be insuffi-
cient, and the remnant proximal spastic segment may affect residual 
symptoms. In a previous case report, a woman with jackhammer 
esophagus was treated with POEM but presented with symptom-
atic recurrence after six months. The high resolution manometry 
showed a remnant spasm segment of the esophageal body proximal 
to the myotomy, and her symptoms could be resolved after endo-
scopic balloon dilation of the proximal spastic segment.55 
The myotomy length should be decided on the basis of the pa-
tients’ manometric, radiological, clinical, and endoscopic findings, 
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especially in patients with SEDs. Although the accumulated data 
are not enough, POEM seems to be a very promising treatment 
option for patients with these SEDs.
Future Perspective of Peroral Endoscopic 
Myotomy  
There have been numerous studies regarding the efficacy and 
application of POEM. It can be used to treat a variety of esopha-
geal motility disorders including all types of achalasia, DES, and 
jackhammer esophagus. However, there is still ongoing discussion 
about the role of POEM in the management algorithm of achala-
sia, and where it stands in relation to balloon dilatation and surgical 
myotomy. 
Further questions have arisen as POEM is being accepted 
widely. The questions include the ideal length of myotomy, the side 
to be cut, and if a full layer endoscopic myotomy or just division of 
the inner circular muscle should be performed. Further evaluation 
with longer observation is needed to evaluate these issues.
POEM has also brought tremendous attention to esophageal 
motility diseases, which includes the etiology of achalasia,62 carci-
nogenesis of the disease,63 and endoscopic diagnosis.64,65 The whole 
story regarding esophageal achalasia may be elucidated in the near 
future. 
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